Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prakash Krishnan

Showing results (101-110 of 176) with videos related to

Pageof 18
Sort By:
Journal of the American College of Cardiology|November 4, 2022
Comparison of Drug-Coated Balloons vs Bare-Metal Stents in Patients With Femoropopliteal Arterial DiseaseMehdi H Shishehbor, Dierk Scheinert, Ashit Jain, et al.
American Heart Journal|June 22, 2015
Gender-specific outcomes after balloon aortic valvuloplasty: Inhospital and long-term outcomesGeorgios Christodoulidis, Jennifer Yu, Annapoorna Kini, et al.
Lancet (London, England)|November 18, 2021
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registryRoxana Mehran, Ruth Owen, Mauro Chiarito, et al.
JACC. Cardiovascular Interventions|October 20, 2012
Open versus endovascular stent graft repair of abdominal aortic aneurysms: a meta-analysis of randomized trialsGeorge Dangas, David O'Connor, Belal Firwana, et al.
Circulation. Cardiovascular Interventions|January 13, 2018
Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized TrialPeter A Schneider, John R Laird, Gunnar Tepe, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|April 1, 2026
Pharmacokinetic Profile of Everolimus Eluted From the Esprit BTK Scaffold: A LIFE-BTK Pharmacokinetics SubstudyJen-Kuang Lee, Richard Pin, Shirley Jansen, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|December 16, 2025
From Coronary Arteries to Lower Limbs: Advances in Drug-Eluting Bioresorbable Scaffolds for Treating Chronic Limb-Threatening IschemiaAndrew Holden, Ramon Varcoe, Brian DeRubertis, et al.
Atherosclerosis|July 12, 2016
Enhanced neointimal fibroblast, myofibroblast content and altered extracellular matrix composition: Implications in the progression of human peripheral artery restenosisPrakash Krishnan, K-Raman Purushothaman, Meerarani Purushothaman, et al.
Plos One|December 17, 2020
Relationship between high shear stress and OCT-verified thin-cap fibroatheroma in patients with coronary artery diseaseNaotaka Okamoto, Yuliya Vengrenyuk, Valentin Fuster, et al.
Journal of the American College of Cardiology|October 19, 2015
Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFAJohn R Laird, Peter A Schneider, Gunnar Tepe, et al.
Pageof 18

Showing results (101-110 of 176) with videos related to

Sort By:
Pageof 18
Journal of the American College of Cardiology|November 4, 2022
Comparison of Drug-Coated Balloons vs Bare-Metal Stents in Patients With Femoropopliteal Arterial DiseaseMehdi H Shishehbor, Dierk Scheinert, Ashit Jain, et al.
American Heart Journal|June 22, 2015
Gender-specific outcomes after balloon aortic valvuloplasty: Inhospital and long-term outcomesGeorgios Christodoulidis, Jennifer Yu, Annapoorna Kini, et al.
Lancet (London, England)|November 18, 2021
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registryRoxana Mehran, Ruth Owen, Mauro Chiarito, et al.
JACC. Cardiovascular Interventions|October 20, 2012
Open versus endovascular stent graft repair of abdominal aortic aneurysms: a meta-analysis of randomized trialsGeorge Dangas, David O'Connor, Belal Firwana, et al.
Circulation. Cardiovascular Interventions|January 13, 2018
Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized TrialPeter A Schneider, John R Laird, Gunnar Tepe, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|April 1, 2026
Pharmacokinetic Profile of Everolimus Eluted From the Esprit BTK Scaffold: A LIFE-BTK Pharmacokinetics SubstudyJen-Kuang Lee, Richard Pin, Shirley Jansen, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|December 16, 2025
From Coronary Arteries to Lower Limbs: Advances in Drug-Eluting Bioresorbable Scaffolds for Treating Chronic Limb-Threatening IschemiaAndrew Holden, Ramon Varcoe, Brian DeRubertis, et al.
Atherosclerosis|July 12, 2016
Enhanced neointimal fibroblast, myofibroblast content and altered extracellular matrix composition: Implications in the progression of human peripheral artery restenosisPrakash Krishnan, K-Raman Purushothaman, Meerarani Purushothaman, et al.
Plos One|December 17, 2020
Relationship between high shear stress and OCT-verified thin-cap fibroatheroma in patients with coronary artery diseaseNaotaka Okamoto, Yuliya Vengrenyuk, Valentin Fuster, et al.
Journal of the American College of Cardiology|October 19, 2015
Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFAJohn R Laird, Peter A Schneider, Gunnar Tepe, et al.
Pageof 18